When you are enrolled in Teva Support Solutions
®, we will let you know if you are eligible for the CINQAIR ® Cost Support Program, based on your commercial insurance coverage.
Watch the Video
* The CINQAIR ® Cost Support Program helps commercially insured individuals in the United States (including the United States territories) who are prescribed CINQAIR ® pay for their eligible out-of-pocket costs for the drug and for administration of the drug, including co-pays, co-insurance, and deductibles. The Program does not cover the costs of physician office visits or evaluations, blood work or other testing, or transportation. Persons residing in the states of Massachusetts, Minnesota, Michigan, and Rhode Island are eligible for financial assistance with their out-of-pocket costs for the drug only and are NOT eligible for other types of financial assistance (administration of the drug). See complete Terms and Conditions. Eligible individuals must have commercial insurance for CINQAIR ®. Uninsured and cash-paying patients are NOT eligible for this Program, nor are individuals with commercial insurance coverage that does not provide coverage for CINQAIR ®.
How the CINQAIR
® Cost Support Program Works
If eligible, we will send you a CINQAIR
® Cost Support Program Card in the mail. Use your CINQAIR ® Cost Support Program Card with your treatment provider to pay your out-of-pocket costs for treatment with CINQAIR ®.
How to use your Cost Support Program Card
Other Support Options
If you have Medicare, Medicaid, TRICARE, or other government insurance, or no insurance, we may be able to help you find programs and foundation support to make treatment more affordable.
Get connected to Teva Support Solutions
Call 1-844-838-2211, Monday–Friday, 9AM–7PM ET
IMPORTANT SAFETY INFORMATION
What is the most important information I should know about CINQAIR
® (reslizumab) Injection?
CINQAIR can cause serious side effects, including:
Serious allergic reactions (anaphylaxis). Serious allergic reactions can happen right after you receive your CINQAIR infusion. These reactions can cause death. Allergic reactions sometimes do not happen right away. Your healthcare provider will watch you during and after you receive your CINQAIR infusion for any signs of a reaction.
Tell your healthcare provider right away if you have any of the following symptoms that may be associated with an allergic reaction:
skin rash (hives)
swelling of your face, lips, mouth, or tongue
symptoms of low blood pressure (fainting, dizziness, light headedness, confusion, fast heart beat)
nausea or abdominal discomfort
What is CINQAIR?
CINQAIR is a prescription medicine used with other asthma medicines for the maintenance treatment of asthma in people aged 18 years of age and older whose asthma is not controlled with the current asthma medicines. When added to other medicines for asthma, CINQAIR helps prevent severe asthma attacks (exacerbations) and can improve your breathing. Medicines such as CINQAIR reduce blood eosinophils. Eosinophils are a type of white blood cell that may contribute to your asthma.
CINQAIR is not used to treat other problems caused by eosinophils.
CINQAIR is not used to treat sudden breathing problems.
It is not known if CINQAIR is safe and effective in children less than 18 years of age.
Do not receive CINQAIR if you are allergic to reslizumab or any of the ingredients in CINQAIR.
See the Full Prescribing Information for a complete list of the ingredients in CINQAIR.
Before receiving CINQAIR, tell your healthcare provider about all of your medical conditions, including if you:
are taking oral or inhaled corticosteroid medicines.
Do not stop taking your corticosteroid unless your healthcare provider tells you to stop. This may cause other symptoms that were controlled by the corticosteroid medicine to come back. have or have had cancer (malignancy).
have a parasitic (helminth) infection.
are pregnant or plan to become pregnant. It is not known if CINQAIR will harm your unborn baby. Tell your healthcare provider if you become pregnant during your treatment with CINQAIR.
are breastfeeding or plan to breastfeed. It is not known if CINQAIR passes into your breast milk. You and your healthcare provider should decide if you will receive CINQAIR and breastfeed. Talk to your healthcare provider about the best way to feed your baby if you receive CINQAIR.
Do not stop taking your other asthma medicines unless your healthcare provider tells you to.
What are the possible side effects of CINQAIR?
CINQAIR may cause serious side effects, including:
See “What is the most important information I should know about CINQAIR?”
abnormal growth of cells or tissue in your body that may or may not be cancer (malignancy)
The most common side effects of CINQAIR include throat pain.
These are not all the possible side effects of CINQAIR.
Call your doctor for medical advice about side effects. You may report side effects to FDA at
Please see including Boxed WARNING for CINQAIR full Prescribing Information, ®.
Are you a healthcare professional?
The information on this site is intended for healthcare professionals in the Unied States. Are you a healthcare professional in the United States?